SIREN : 750632697
THERAKOS (FRANCE) SAS is a French company founded 14 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in PARIS (75016), this company of category PME shows in 2023 a revenue of 3.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Kennzahl | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Umsatz | 3 249 214 € | 3 365 638 € | 2 655 741 € | 3 013 982 € | 2 937 705 € | 3 043 463 € | 2 520 383 € | N/C |
| Nettoergebnis | 100 336 € | 101 787 € | 76 250 € | 53 833 € | 78 427 € | 45 385 € | 61 586 € | 73 176 € |
| EBITDA | 92 326 € | 74 874 € | 52 701 € | 211 533 € | -246 564 € | 120 788 € | -141 095 € | N/C |
| Nettomarge | 3.1% | 3.0% | 2.9% | 1.8% | 2.7% | 1.5% | 2.4% | N/C |
In 2023, THERAKOS (FRANCE) SAS achieves revenue of 3.2 M€. Revenue is growing positively over 8 years (CAGR: +4.3%). Slight decline of -3% vs 2022. After deducting consumption (0 €), gross margin stands at 3.2 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 92 k€, representing 2.8% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 100 k€, i.e. 3.1% of revenue. This profit can be retained or distributed to shareholders.
3 249 214 €
3 249 214 €
92 326 €
155 045 €
100 336 €
2.8%
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 1.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
4.467%
44.15%
1.165%
0.046
In 2023, the debt ratio of THERAKOS (FRANCE) SAS (4.47) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of THERAKOS (FRANCE) SAS (44.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2023, the repayment capacity of THERAKOS (FRANCE) SAS (0.05) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 163.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
163.441
0.0
In 2023, the liquidity ratio of THERAKOS (FRANCE) SAS (163.44) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2023, the interest coverage of THERAKOS (FRANCE) SAS (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 24 days. Favorable situation: supplier credit is longer than customer credit by 24 days. Overall, WCR represents 28 days of revenue, i.e. 250 k€ to permanently finance.
249 670 €
0 j
24 j
0 j
28 j
Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 20 018€ to 61 530€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare THERAKOS (FRANCE) SAS with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques
The revenue of THERAKOS (FRANCE) SAS in 2023 is 3.2 M€.
Yes, THERAKOS (FRANCE) SAS generated a net profit of 100 k€ in 2023.
The headquarters of THERAKOS (FRANCE) SAS is located in PARIS (75016), in the department Paris.
The tax return of THERAKOS (FRANCE) SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
THERAKOS (FRANCE) SAS operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.